Phytochemical Constituents from Globimetula oreophila as Plasmepsin I and II Inhibitors in Antimalarial Drug Discovery: An In Silico Approach
Authors:
- Dauda GarbaDauda Garba
- Bila Hassan AliBABila Hassan Ali
- Bashar BawaBBBashar Bawa
- Abdullahi MaryamAMAbdullahi Maryam
- Hamza Asmau NasiruHNHamza Asmau Nasiru
- Yahaya Mohammed SaniYSYahaya Mohammed Sani
- Muhammad Garba MagajiMMMuhammad Garba Magaji
- Musa Isma’il AbdullahiMAMusa Isma’il Abdullahi
- Aliyu Muhammad MusaAMAliyu Muhammad Musa
- Hassan Halimatu SadiyaHSHassan Halimatu Sadiya
Open Access
- 14 November 2024
- conference paper
- Published by MDPI AG in Chemistry Proceedings
- Vol. 16 (1) , 42
Abstract
Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. This study investigates the inhibitory properties of quercetin, quercetrin, dihydrostilbene, 4′-methoxy-isoliquiritigenin, and stigmasterol from Globimetula oreophila on plasmepsins through in silico techniques, including ADME predictions and molecular docking. Results reveal strong interactions of these compounds with active site residues, with quercetrin and stigmasterol displaying notable binding affinities. These findings suggest the potential of G. oreophila metabolites as potent plasmepsin inhibitors, offering prospects for malaria treatment and prevention.Keywords
This publication has 11 references indexed in Scilit:
- Qualitative and quantitative phytochemical profiling of ethnomedicinal folklore plant- Globimetula oreophilaJournal of Current Biomedical Research, 2023
- Levels of trace metals content of crude ethanol leaf extract of globimetula oreophila (Hook. f) danser growing on Azadirachta indica using atomic absorption spectroscopyJournal of Current Biomedical Research, 2023
- Antimalarial Activity of 4-Metoxychalcones: Docking Studies as Falcipain/Plasmepsin Inhibitors, ADMET and Lipophilic Efficiency Analysis to Identify a Putative Oral Lead CandidateMolecules, 2013
- Malaria biology and disease pathogenesis: insights for new treatmentsNature Medicine, 2013
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparumJournal of Structural Biology, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Novel Uncomplexed and Complexed Structures of Plasmepsin II, an Aspartic Protease from Plasmodium falciparumJournal of Molecular Biology, 2003